conjugate formation are under way. The synthetic methods de-
scribed herein will serve to generate additional chemical struc-
tures that will facilitate these studies, as well as provide
synthetic access to MacE.
Materials and Methods
Cell Culture. NRK and HeLa cells were grown in Advanced DMEM (Invitrogen),
supplemented with 2% FBS and 2 mM glutaMAX-I (GIBCO) in a 5% CO2
incubator.
Antibodies and Reagents Used in This Study. Anti-giantin, anti-β-COP and anti-
GRASP65 (Sütterlin Lab), anti-Golgin-97 [kindly provided by Ed Chan (Univer-
sity of Florida)], anti-mannosidase II [kindly provided by Kelley Moreman
(University of Georgia)], anti-calreticulin and anti-α-tubulin (Sigma) were
used. BFA was from MP Biochemicals; phalloidin-Rhodamine was from Sigma.
Fluorochrome-conjugated secondary antibodies were from Invitrogen.
Scheme 4 In situ observation of 26 and synthesis of 27 and 28.
(Scheme 4). A feasible mechanism to explain the conversion of
the oxygenated core of t-Bu-MacE and analog 8 to pyrrole pro-
ducts consists of nucleophilic addition to the C16 acetoxy group
and breakdown of the ensuing tetrahedral intermediate to
generate a transient dialdehyde (9, Scheme 2) that subsequently
undergoes Paal–Knorr-type pyrrole formation (39). Elimination
of the C12 acetoxy group and benzylamine addition to the resul-
tant α,β-unsaturated iminium leads to the formation of 26.
Subsequent addition of CSA promotes amine exchange with
methanol and Fisher esterification to give 27.
These findings highlight a potential functional role for the oxy-
genated dioxabicyclo[3.2.1]octanone as a masked 1,4-dialdehyde
progenitor leading to a protein bound pyrrole species. The reac-
tion of 1,4-dicarbonyl compounds with lysine residues to form
pyrrole-protein conjugates has been proposed as the origin of cel-
lular toxicity of n hexane via in vivo formation of 2,5-hexadione
and levuglandin E2, a δ-keto aldehyde derived from the pro-
staglandin precursor endoperoxide H2 (40, 41). An additional
feature, apparent from the observed formation of 26 and 27, is
the role of the C12 acetoxy group as a latent leaving group
enabling the formation of structures that possess two sites of
covalent modifications via pyrrole formation and subsequent
C12 reactivity. The requirement of acetoxy groups at C12 and
C16 to induce the unique Golgi phenotype reported herein
suggests that pyrrole formation and potentially cross-linking
might be involved in mediating the interaction of MacE and
t-Bu-MacE with the putative biological target.
Immunofluorescence. NRK or HeLa cells grown on coverslips were fixed for
10 min in 4% formaldehyde in PBS and incubated in blocking buffer
(2.5% FBS, 0.1% Triton-X 100). Primary and secondary antibodies were di-
luted into blocking buffer. Cells were imaged with a Zeiss Axiovert 200M
microscope and analyzed with linear adjustments with the Zeiss Axiovision
software.
Compound Treatment. NRK cells on coverslips were treated with MacE,
t-Bu-MacE, and BFA at the indicated concentration in complete medium
supplemented with 25 mM Hepes pH 7.4 for the indicated periods of time.
Control incubations were done with DMSO.
Electron Microscopy. NRK cells were grown in 6 well dishes and treated with
DMSO, MacE, or t-Bu-MacE for 60 min. After their fixation with 1% glutar-
aldehyde in Hepes buffer, they were harvested by scraping, washed in PBS,
embedded in Epon 812, and cut into thin sections. Analysis of thin sections
was performed under a Tecnai-12 electron microscope (FEI/Philips). Images
were taken using an ULTRA VIEW CCD digital camera. Morphometric analysis
of Golgi stacks was performed in 20 cells (1–4 stacks per cell) for each experi-
mental condition (overall; 41 stacks in DMSO, 38 in MacE, and 43 in
t-Bu-MacE) using the ANALYSIS software.
Transport of VSV-GtsO45-GFP. HeLa cells grown on coverslips were transfected
with the plasmid VSV-GtsO45-GFP (37) and left at 37 °C for 24 h. Cells were
then shifted to 40.5 °C for 5 h and an additional 1 h in the presence of DMSO,
MacE, or t-Bu-MacE. The cells were then fixed or shifted to 32 °C for 60 min
to allow protein transport to the cell surface. Arrival of VSV-GtsO45-GFP at the
cell surface was quantified in at least 100 cells per each experimental
condition.
Conclusions. A unique Golgi phenotype has been identified for the
spongian diterpene MacE (4) defined by fragmentation of the
Golgi ribbon with localization of the Golgi fragments in the peri-
centriolar region and concurrent block of protein transport out of
the Golgi. Limited access to significant quantities of the natural
product prompted the development of a synthesis of the substi-
tuted dioxabicyclo[3.2.1]octanone ring system characteristic of
MacE and related natural products. These studies included the
synthesis of the truncated analog t-Bu-MacE, which induces
the MacE Golgi phenotype, and other analogs whose biological
studies outlined key elements of the structure activity relation-
ships in this series. In addition, t-Bu-MacE was found to be less
cytotoxic than MacE. The conversion of the oxygenated core of
these MacE analogs to pyrrole products has suggested a potential
mechanism of action for these compounds. Further studies direc-
ted at elucidating the target and the relevance of pyrrole-protein
Compounds. See SI Appendix for experimental details, 1H and 13C NMR spec-
tra of previously undescribed compounds, and x-ray structures of t-Bu-MacE
(7) and compound 17.
ACKNOWLEDGMENTS. We thank Dr. Joe Ziller, University of California, Irvine,
for the single-crystal x-ray analyses and Dr. John Greaves, University of
California, Irvine, for mass spectrometric analyses. We gratefully acknowl-
edge the late Professor John Faulkner, Scripps Institution of Oceanography
(SIO), for encouragement and authentic macfarlandin E. We thank Professor
Gerwick, SIO, and Dr. Hyukjae Choi, SIO, for purification and access to
authentic aplyviolene. This research was supported by the NIH Neurological
Disorders & Stroke Institute (Grant NS-12389) and by NIH postdoctoral
fellowship support for M.J.S. (CA-138084) and C.M.B. (GM-079937). NMR,
mass spectra, and the x-ray analyses were obtained at UC Irvine using
instrumentation acquired with the assistance of NSF and NIH Shared Instru-
mentation grants. Unrestricted funds from Amgen, Merck, and Roche
Biosciences are also gratefully acknowledged.
1. Klausner RD, Donaldson JG, Lippincott-Schwartz J (1992) Brefeldin A: Insights into the
control of membrane traffic and organelle structure. J Cell Biol 116:1071–1080.
2. Donaldson JG, Finazzi D, Klausner RD (1992) Brefeldin A inhibits Golgi membrane-
catalysed exchange of guanine nucleotide onto ARF protein. Nature 360:350–352.
3. Renault L, Guibert B, Cherfils J (2003) Structural snapshots of the mechanism and
inhibition of a guanine nucleotide exchange factor. Nature 426:525–530.
4. Takizawa PA, et al. (1993) Complete vesiculation of Golgi membranes and
inhibition of protein-transport by a novel sea sponge metabolite, ilimaquinone. Cell
73:1079–1090.
5. Radeke HS, Digits CA, Casaubon RL, Snapper ML (1999) Interactions of (−)-ilimaqui-
none with methylation enzymes: Implications for vesicular-mediated secretion. Chem
Biol 6:639–647.
6. Jamora C, et al. (1997) Regulation of Golgi structure through heterotrimeric
G proteins. Cell 91:617–626.
7. Jamora C, et al. (1999) Gβγ-Mediated regulation of Golgi organization is through the
direct activation of protein kinase D. Cell 98:59–68.
8. Liljedahl M, et al. (2001) Protein kinase D regulates the fission of cell surface destined
transport carriers from the trans-Golgi network. Cell 104:409–420.
6162
∣
Schnermann et al.